{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:05:39Z","timestamp":1757617539119,"version":"3.44.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10157-025-02651-6","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T12:00:31Z","timestamp":1741694431000},"page":"1053-1062","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Booster effect of the fourth dose of the SARS-CoV-2 mRNA vaccine in kidney transplant recipients"],"prefix":"10.1007","volume":"29","author":[{"given":"Ayaka","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuko","family":"Kawabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9856-0852","authenticated-orcid":false,"given":"Izumi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaro","family":"Ohki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akimitsu","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Urabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Miki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanae","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yudo","family":"Tanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Horino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Ohkido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyasu","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yokoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"issue":"13","key":"2651_CR1","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239\u201342.","journal-title":"JAMA"},{"issue":"3","key":"2651_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1056\/NEJMoa2107456","volume":"385","author":"RW Frenck Jr","year":"2021","unstructured":"Frenck RW Jr, et al. Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents. N Engl J Med. 2021;385(3):239\u201350.","journal-title":"N Engl J Med"},{"issue":"10","key":"2651_CR3","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41577-021-00592-1","volume":"21","author":"JS Tregoning","year":"2021","unstructured":"Tregoning JS, et al. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol. 2021;21(10):626\u201336.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"2651_CR4","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.kint.2020.03.018","volume":"97","author":"D Banerjee","year":"2020","unstructured":"Banerjee D, et al. COVID-19 infection in kidney transplant recipients. Kidney Int. 2020;97(6):1076\u201382.","journal-title":"Kidney Int"},{"issue":"12","key":"2651_CR5","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1111\/ajt.16742","volume":"21","author":"D Kremer","year":"2021","unstructured":"Kremer D, et al. A systematic review and meta-analysis of COVID-19 in kidney transplant recipients: Lessons to be learned. Am J Transpl. 2021;21(12):3936\u201345.","journal-title":"Am J Transpl"},{"issue":"2","key":"2651_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40472-021-00322-5","volume":"8","author":"VK Phadke","year":"2021","unstructured":"Phadke VK, Scanlon N, Jordan SC, Rouphael NG. Immune responses to SARS-CoV-2 in solid organ transplant recipients. Curr Transpl Rep. 2021;8(2):127\u201339.","journal-title":"Curr Transpl Rep"},{"issue":"11","key":"2651_CR7","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/jama.2021.12339","volume":"326","author":"I Benotmane","year":"2021","unstructured":"Benotmane I, et al. Antibody response after a third dose of the mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients with minimal serologic response to 2 doses. JAMA. 2021;326(11):1063\u20135.","journal-title":"JAMA"},{"issue":"7","key":"2651_CR8","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1056\/NEJMc2108861","volume":"385","author":"N Kamar","year":"2021","unstructured":"Kamar N, et al. Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients. N Engl J Med. 2021;385(7):661\u20132.","journal-title":"N Engl J Med"},{"issue":"13","key":"2651_CR9","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1056\/NEJMc2111462","volume":"385","author":"VG Hall","year":"2021","unstructured":"Hall VG, et al. Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients. N Engl J Med. 2021;385(13):1244\u20136.","journal-title":"N Engl J Med"},{"key":"2651_CR10","doi-asserted-by":"publisher","first-page":"101864","DOI":"10.1016\/j.trim.2023.101864","volume":"79","author":"Y Kuniduzi","year":"2023","unstructured":"Kuniduzi Y, et al. Efficacy and safety of a fourth dose of the COVID-19 vaccine in kidney transplant recipients: a systematic review and meta-analysis. Transpl Immunol. 2023;79:101864.","journal-title":"Transpl Immunol"},{"issue":"1","key":"2651_CR11","doi-asserted-by":"publisher","first-page":"9976","DOI":"10.1038\/s41598-023-36998-1","volume":"13","author":"M Kawabe","year":"2023","unstructured":"Kawabe M, et al. Booster effect of the third dose of SARS-CoV-2 mRNA vaccine in Japanese kidney transplant recipients. Sci Rep. 2023;13(1):9976.","journal-title":"Sci Rep"},{"issue":"13","key":"2651_CR12","doi-asserted-by":"publisher","first-page":"922042","DOI":"10.3389\/fmicb.2022.922042","volume":"9","author":"Y Ohki","year":"2022","unstructured":"Ohki Y, et al. Long-term humoral response after a second dose of SARS-CoV-2 mRNA vaccine in Japanese kidney transplant recipients. Front Microbiol. 2022;9(13):922042.","journal-title":"Front Microbiol"},{"issue":"5","key":"2651_CR13","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.kint.2022.02.011","volume":"101","author":"I Benotmane","year":"2022","unstructured":"Benotmane I, et al. A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients. Kidney Int. 2022;101(5):1073\u20136.","journal-title":"Kidney Int"},{"issue":"23\u201324","key":"2651_CR14","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00508-022-02103-1","volume":"134","author":"C Brandstetter","year":"2022","unstructured":"Brandstetter C, et al. Humoral response after a third and fourth dose of mRNA-based SARS-CoV-2 vaccine in previously seronegative kidney transplant recipients. Wien Klin Wochenschr. 2022;134(23\u201324):815\u201321.","journal-title":"Wien Klin Wochenschr"},{"issue":"9","key":"2651_CR15","doi-asserted-by":"publisher","first-page":"e420","DOI":"10.1097\/TP.0000000000004219","volume":"106","author":"MP Cristelli","year":"2022","unstructured":"Cristelli MP, et al. The fourth dose of CoronaVac vaccine results in a small increase of seroconversion and antibody values among kidney transplant recipients. Transplantation. 2022;106(9):e420\u20131.","journal-title":"Transplantation"},{"issue":"6","key":"2651_CR16","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.kint.2021.04.005","volume":"99","author":"I Benotmane","year":"2021","unstructured":"Benotmane I, et al. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine. Kidney Int. 2021;99(6):1498\u2013500.","journal-title":"Kidney Int"},{"issue":"10","key":"2651_CR17","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3390\/vaccines9101165","volume":"9","author":"A D\u0119bska-\u015alizie\u0144","year":"2021","unstructured":"D\u0119bska-\u015alizie\u0144 A, et al. Predictors of humoral response to mRNA COVID19 vaccines in kidney transplant recipients: a longitudinal study\u2014the COViNEPH project. Vaccines (Basel). 2021;9(10):1165.","journal-title":"Vaccines (Basel)"},{"issue":"11","key":"2651_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001397","volume":"8","author":"SC Fr\u00f6lke","year":"2022","unstructured":"Fr\u00f6lke SC, et al. Predictors of nonseroconversion to SARS-CoV-2 vaccination in kidney transplant recipients. Transpl Direct. 2022;8(11): e1397. https:\/\/doi.org\/10.1097\/TXD.0000000000001397.","journal-title":"Transpl Direct"},{"issue":"4","key":"2651_CR19","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.kint.2022.01.017","volume":"101","author":"C Masset","year":"2022","unstructured":"Masset C, et al. A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients. Kidney Int. 2022;101(4):825\u20136.","journal-title":"Kidney Int"},{"issue":"8","key":"2651_CR20","doi-asserted-by":"publisher","first-page":"1173.e1","DOI":"10.1016\/j.cmi.2021.04.028","volume":"27","author":"B Rozen-Zvi","year":"2021","unstructured":"Rozen-Zvi B, et al. Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study. Clin Microbiol Infect. 2021;27(8):1173.e1-1173.e4.","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"2651_CR21","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1111\/ajt.17091","volume":"22","author":"K Midtvedt","year":"2022","unstructured":"Midtvedt K, et al. Fourth dose of the SARS-CoV-2 vaccine in kidney transplant recipients with previously impaired humoral antibody response. Am J Transpl. 2022;22(11):2704\u20136.","journal-title":"Am J Transpl"},{"issue":"Suppl 1","key":"2651_CR22","doi-asserted-by":"publisher","first-page":"i21","DOI":"10.1093\/ckj\/sfab030","volume":"14","author":"N Toapanta","year":"2021","unstructured":"Toapanta N, et al. Kidney transplantation and COVID-19 renal and patient prognosis. Clin Kidney J. 2021;14(Suppl 1):i21\u20139.","journal-title":"Clin Kidney J"},{"key":"2651_CR23","unstructured":"Japanese Society for Transplantation COVID-19 Task Force. Available online at: https:\/\/square.umin.ac.jp\/jst-covid-19\/images\/20220831covid-19cases.pdf. Accessed on 23 Nov 2022."},{"key":"2651_CR24","unstructured":"Ministry of Health, Labour and Welfare. Available online at: https:\/\/www.mhlw.go.jp\/content\/10906000\/000970173.pdf. Accessed on 23 Nov 2022."},{"issue":"12","key":"2651_CR25","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1097\/TP.0000000000004371","volume":"106","author":"A Sahota","year":"2022","unstructured":"Sahota A, et al. Incidence, risk factors, and outcomes of COVID-19 infection in a large cohort of solid organ transplant recipients. Transplantation. 2022;106(12):2426\u201334.","journal-title":"Transplantation"},{"issue":"4","key":"2651_CR26","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s44197-021-00015-3","volume":"11","author":"H Rahimzadeh","year":"2021","unstructured":"Rahimzadeh H, et al. The tsunami of COVID-19 infection among kidney transplant recipients: a single-center study from Iran. J Epidemiol Glob Health. 2021;11(4):389\u201396.","journal-title":"J Epidemiol Glob Health."},{"issue":"10","key":"2651_CR27","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1681\/ASN.2020050639","volume":"31","author":"M Elias","year":"2020","unstructured":"Elias M, et al. COVID-19 infection in kidney transplant recipients: disease incidence and clinical outcomes. J Am Soc Nephrol. 2020;31(10):2413\u201323.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"2651_CR28","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","volume":"27","author":"S Feng","year":"2021","unstructured":"Feng S, et al. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nat Med. 2021;27(11):2032\u201340.","journal-title":"Nat Med"},{"issue":"6576","key":"2651_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1126\/science.abm3425","volume":"375","author":"PB Gilbert","year":"2022","unstructured":"Gilbert PB, et al. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial. Science. 2022;375(6576):43\u201350.","journal-title":"Science"},{"issue":"2","key":"2651_CR30","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","volume":"23","author":"P Moss","year":"2022","unstructured":"Moss P. The T cell immune response against SARS-CoV-2. Nat Immunol. 2022;23(2):186\u201393.","journal-title":"Nat Immunol"},{"issue":"1","key":"2651_CR31","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","volume":"183","author":"T Sekine","year":"2020","unstructured":"Sekine T, et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell. 2020;183(1):158-168.e14.","journal-title":"Cell"},{"issue":"71","key":"2651_CR32","doi-asserted-by":"publisher","first-page":"eabo1303","DOI":"10.1126\/sciimmunol.abo1303","volume":"7","author":"S Vardhana","year":"2022","unstructured":"Vardhana S, et al. Understanding T cell responses to COVID-19 is essential for informing public health strategies. Sci Immunol. 2022;7(71):eabo1303.","journal-title":"Sci Immunol."}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02651-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-025-02651-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02651-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T07:36:40Z","timestamp":1757144200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-025-02651-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2651"],"URL":"https:\/\/doi.org\/10.1007\/s10157-025-02651-6","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"type":"print","value":"1342-1751"},{"type":"electronic","value":"1437-7799"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"26 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee at which the studies were conducted (IRB approval number 33-314 [10934]) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all individual participants included in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}